Taiwan FDA registration dc6b398ecde565557b15e19d575264ef
LONG TERM BZD TEST
TW: 龍騰苯二氮泮體外試劑組
Taiwan·Risk Class 2·MD·Longteng Biotechnology Co., Ltd. new market factory·Registered Jun 08, 2020 – Jun 08, 2025ExpiredRegistration details
- Analysis ID
- dc6b398ecde565557b15e19d575264ef
- License Form
- Ministry of Health Medical Device Manufacturing No. 006712
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Longteng Biotechnology Co., Ltd. new market factory
Product details
- Intended Use
- Qualitative detection of benzodiazepine and its metabolites in human urine. This product can be used by physicians or medical examiners and the general public.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A3170 Benzene (para)dinitrogen test system
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jun 08, 2020
- Expiry Date
- Jun 08, 2025
About this record
Access comprehensive regulatory information for LONG TERM BZD TEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dc6b398ecde565557b15e19d575264ef and manufactured by Longteng Biotechnology Co., Ltd. new market factory. The authorized representative in Taiwan is Longteng Biotechnology Co., Ltd. new market factory.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices